US 11608380
Anti-EGFRvIII antibodies and uses thereof
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11608380 (Anti-EGFRvIII antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K39/3955, A61K39/39558